A pharmacokinetic model for the glycation of albumin

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 39, Issue 3, 2012, Pages 273-282

  Alskär, Oskar ^a   Korell, Julia ^b   Duffull, Stephen B ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Chronic kidney disease; Clinical trial simulations; Glycated albumin; HbA1c; NONMEM

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ARTICLE; DIABETES MELLITUS; ERYTHROCYTE; ERYTHROPOIESIS; GLUCOSE BLOOD LEVEL; GLYCATION; GLYCEMIC CONTROL; HUMAN; PRIORITY JOURNAL; SIMULATION; STATISTICAL MODEL;

AGED; BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SERUM ALBUMIN;

EID: 84865503843     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-012-9249-1     Document Type: Article

References (46)

1. Wild SH, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(10):2569
2. Control TD, Graup CTR (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977-986
3. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321(7258):405
4. Tessier FJ (2010) The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathologie Biologie 58(3):214-219
5. Monnier VM (2003) Intervention against the Maillard reaction in vivo. Arch Biochem Biophys 419(1):1-15. doi:10.1016/j.abb. 2003.08.014
6. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB (2004) Tests of glycemia in diabetes. Diabetes Care 27(7):1761-1773. doi:10.2337/diacare.27.7.1761
7. Reynolds TM, Smellie W, Twomey PJ (2006) Glycated haemoglobin (HbA1c) monitoring. Br Med J 333(7568):586
8. Ly J, Marticorena R, Donnelly S (2004) Red blood cell survival in chronic renal failure. Am J Kidney Dis 44(4):715-719
9. Brown JN, Kemp DW, Brice KR (2009) Class effect of erythropoietin therapy on hemoglobin A1c in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy 29(4):468-472
10. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E (2007) Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18(3):896-903
11. Fukuoka K, Nakao K, Morimoto H, Nakao A, Takatori Y, Arimoto K, Taki M, Wada J, Makino H (2008) Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology 13(4):278-283
12. Peacock T, Shihabi Z, Bleyer A, Dolbare E, Byers J, Knovich M, Callers-Escandon J, Russell G, Freedman B (2008) Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int 73(9):1062-1068
13. Mehrotra R, Kalantar-Zadeh K, Adler S (2011) Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol 6(7): 1520-1522
14. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S (2006) Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb versus glycated albumin (GA). J Med Invest 53(3-4):223-238
15. Challenge and Opportunity on the Critical Path to New Medical Products (2004) US Food and drug administration. http://www. fda.gov/ScienceResearch/ SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262. htm. Accessed 14 October 2011
16. Kalicki R, Lledo R, Karlsson M (2009) Modeling of red blood cell life-span in a hematologically normal population. In: PAGE, vol Abstr 1677. Petersburg, Russia
17. Beeken WL, Volwiler W, Goldsworthy PD, Garby LE, Reynolds WE, Stogsdill R, Stemler RS (1962) Studies of I131-albumin catabolism and distribution in normal young male adults. J Clin Invest 41(6):1312
18. Cohen S, Freeman T, McFarlane A (1961) Metabolism of I-131- labelled human albumin. Clin Sci 20:161
19. Dykes P (1968) The rates of distribution and catabolism of albumin in normal subjects and in patients with cirrhosis of the liver. Clin Sci 34(1):161
20. Takeda Y, Reeve E (1963) Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men. J lab Clin Med 61:183
21. Baynes JW, Thorpe SR, Murtiashaw MH, Finn Wold KM (1984) Nonenzymatic glucosylation of lysine residues in albumin. In: Methods in enzymology, vol 106. Academic Press, New York, pp 88-98
22. Ferreira AEN, Freire AMJP, Voit EO (2003) A quantitative model of the generation of N (epsilon)-(carboxymethyl) lysine in the Maillard reaction between collagen and glucose. Biochem J 376(Pt 1):109
23. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A (2007) Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 40(18):1398-1405
24. Hess CT (2005) Wound care. Lippincott Williams & Wilkins, Philadelphia
25. Higgins PJ, Bunn HF (1981) Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem 256(10):5204
26. Nathan D, Turgeon H, Regan S (2007) Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 50(11):2239-2244
27. Beutler E, Waalen J (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107(5):1747
28. Daly ME, Vale C, Walker M, Littlefield A, Alberti K, Mathers JC (1998) Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr 67(6):1186
29. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL (2000) Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled doseresponse study. The Pioglitazone 001 Study Group. Diabetes Care 23(11):1605-1611. doi:10.2337/diacare.23.11.1605
30. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ (2012) Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology 17(2):182-188
31. Tozer TN, Rowland M (2006) Introduction to pharmacokinetics and pharmacodynamics: the quantitative basis of drug therapy. Lippincott Williams & Wilkins, Philadelphia
32. McFarlane A (1957) The behavior of I131-labeled plasma proteins in vivo. Ann NY Acad Sci 70(1):19-25
33. Peters T, ScienceDirect (1996) All about albumin: biochemistry, genetics, and medical applications. Academic Press, San Diego
34. Evans TW (2002) Review article: albumin as a drug - biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 16:6-11. doi:10.1046/j.1365-2036.16.s5.2.x
35. Iberg N, Flückiger R (1986) Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem 261(29):13542
36. Shilton B, Walton D (1991) Sites of glycation of human and horse liver alcohol dehydrogenase in vivo. J Biol Chem 266(9):5587
37. Shapiro R, McManus M, Zalut C, Bunn H (1980) Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem 255(7):3120
38. Watkins N, Thorpe S, Baynes J (1985) Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose. J Biol Chem 260(19):10629
39. Watkins N, Neglia-Fisher C, Dyer D, Thorpe S, Baynes J (1987) Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem 262(15):7207
40. Kaysen GA, Schoenfeld PY (1984) Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25(1):107-114
41. Waldmann TA (1972) Protein-losing enteropathy and kinetic studies of plasma protein metabolism. Elsevier, pp 251-264
42. Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlic PJ (1993) Albumin synthesis rates in cirrhosis: correlation with child turcotte classification. Hepatology 18(2):292-297
43. Pasanisi F, Orban A, Scalfi L, Alfonsi L, Santarpia L, Zurlo E, Celona A, Potenza A, Contaldo F (2001) Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 17(7-8):581-584
44. Ruot B, Breuillé D, Rambourdin F, Bayle G, Capitan P, Obled C (2000) Synthesis rate of plasma albumin is a good indicator of liver albumin synthesis in sepsis. Am J Physiol-Endocrinol Metab 279(2):E244
45. Kaysen GA (1993) Plasma composition in the nephrotic syndrome. Am J Nephrol 13(5):347-359
46. Roohk HV, Zaidi AR (2008) A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol (Online) 2(6):1114